Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10). (Q44077833)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10). |
scientific article |
Statements
1 reference
Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10). (English)
1 reference
1 reference
1 reference
Lawrence C S Tam
1 reference
Anna-Sophia Kiang
1 reference
Avril Kennan
1 reference
Paul F Kenna
1 reference
Naomi Chadderton
1 reference
Arpad Palfi
1 reference
Aileen Aherne
1 reference
Matthew Campbell
1 reference
Alex McKee
1 reference
Marian M Humphries
1 reference
G Jane Farrar
1 reference
Pete Humphries
1 reference
1 April 2008
1 reference
1 reference
Identifiers
1 reference